In: Finance
VALIUM’S MEDICAL SUPPLY CORPORATION | ||||||||||||||||
Balance Sheet as of December 31, 2018 and 2017 | ||||||||||||||||
(in thousands of dollars) | ||||||||||||||||
Assets | 2018 | 2017 | Liabilities and Equity | 2018 | 2017 | |||||||||||
Current assets: | Current liabilities: | |||||||||||||||
Cash and marketable securities | $ | 72 | $ | 71 | Accrued wages and taxes | $ | 46 | $ | 41 | |||||||
Accounts receivable | 187 | 181 | Accounts payable | 147 | 141 | |||||||||||
Inventory | 312 | 291 | Notes payable | 131 | 131 | |||||||||||
Total | $ | 571 | $ | 543 | Total | $ | 324 | $ | 313 | |||||||
Fixed assets: | Long-term debt | $ | 568 | $ | 556 | |||||||||||
Gross plant and equipment | $ | 1,073 | $ | 882 | Stockholders’ equity: | |||||||||||
Less: Accumulated depreciation | 146 | 113 | Preferred stock (6 thousand shares) | $ | 6 | $ | 6 | |||||||||
Net plant and equipment | $ | 927 | $ | 769 | Common stock and paid-in surplus (100 thousand shares) | 120 | 120 | |||||||||
Other long-term assets | 134 | 134 | Retained earnings | 614 | 451 | |||||||||||
Total | $ | 1,061 | $ | 903 | Total | $ | 740 | $ | 577 | |||||||
Total assets | $ | 1,632 | $ | 1,446 | Total liabilities and equity | $ | 1,632 | $ | 1,446 | |||||||
VALIUM’S MEDICAL SUPPLY CORPORATION | |||||||
Income Statement for Years Ending December 31, 2018 and 2017 | |||||||
(in thousands of dollars) | |||||||
2018 | 2017 | ||||||
Net sales | $ | 892 | $ | 802 | |||
Less: Cost of goods sold | 389 | 352 | |||||
Gross profits | $ | 503 | $ | 450 | |||
Less: Other operating expenses | 47 | 41 | |||||
Earnings before interest, taxes, depreciation, and amortization (EBITDA) | $ | 456 | $ | 409 | |||
Less: Accumulated depreciation | 33 | 31 | |||||
Earnings before interest and taxes (EBIT) | $ | 423 | $ | 378 | |||
Less: Interest | 48 | 42 | |||||
Earnings before taxes (EBT) | $ | 375 | $ | 336 | |||
Less: Taxes | 131 | 111 | |||||
Net income | $ | 244 | $ | 225 | |||
Less: Preferred stock dividends | $ | 6 | $ | 6 | |||
Net income available to common stockholders | $ | 238 | $ | 219 | |||
Less: Common stock dividends | 75 | 75 | |||||
Addition to retained earnings | $ | 163 | $ | 144 | |||
Per (common) share data: | |||||||
Earnings per share (EPS) | $ | 2.38 | $ | 2.19 | |||
Dividends per share (DPS) | $ | 0.75 | $ | 0.75 | |||
Book value per share (BVPS) | $ | 7.34 | $ | 5.71 | |||
Market value (price) per share (MVPS) | $ | 8.37 | $ | 6.19 | |||
Prepare a statement of cash flows for Valium’s Medical Supply Corporation. (Enter your answers in thousands. Amounts to be deducted should be indicated with a minus sign.)
|
The cash flow statement is prepared as follows:
Statement of Cash Flows for Year Ending December 31, 2018 | |
(in thousands of dollars) | |
Cash Flow from Operating Activities | |
Net Income | 244 |
Additions (Sources of Cash) | |
Depreciation | 33 |
Increase in Accrued Wages and Taxes (46-41) | 5 |
Increase in Accounts Payable (147-141) | 6 |
Subtractions (Uses of Cash) | |
Increase in Accounts Receivable (187-181) | -6 |
Increase in Inventory (312-291) | -21 |
Net Cash Flow from Operating Activities (A) | 261 |
Cash Flow from Investing Activities | |
Subtractions: | |
Increase in Fixed Assets (1,073-882) | -191 |
Net Cash Flow from Investing Activities (B) | -191 |
Cash Flow from Financing Activities | |
Additions: | |
Increase in Long Term Debt (568-556) | 12 |
Subtractions: | |
Payment of Common Stock Dividends | -75 |
Payment of Preferred Stock Dividends | -6 |
Net Cash Flow from Financing Activities (C) | -69 |
Net Change in Cash and Marketable Securities (A+B+C) | $1 |
Add Opening Cash and Marketable Securities | $71 |
Closing Cash and Marketable Securities | $72 |
_____
Notes:
1) Increase in current assets and decrease in current liabilities (if any) is recorded as a subtraction/decrease in cash flow from operating activities.
2) Decrease in current assets (if any) and increase in current liabilities is recorded as an addition/increase in cash flow from operating activities.